CAS: 32852-81-6; 3-Phenoxyphenylacetic Acid

该化合物是一种有机化合物,其特征为苯氧基和苯乙酸功能组,通常看起来像白色到非白固体,在有机溶剂中可溶解,但水中溶解性有限;该化合物的特征为苯氧基组,其芳香特性有助于其芳香特性,以及产生酸性特征的乙酸酶;其分子结构允许在制药和农用化学品中潜在应用,特别是作为各种生物活性化合物合成的一个构件;该化合物可能展示生物活动,包括潜在的反炎或止痛效应,尽管具体的生物特性可能因结构改变和存在亚化物而不同.与许多有机酸一样,重要的是要谨慎地处理三-苯基乙酸,并遵循适当的安全议定书,以减少与使用该物质有关的任何风险.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号53874-66-1 3-苯氧基苄氯 | CAS号109330-01-0 (3-苯氧基苯基)乙醛 | CAS号66644-22-2 ethyl (3-phenox... | CAS号51632-29-2 3-苯氧基苯乙腈 | CAS号39515-51-0 间苯氧基苯甲醛 | CAS号51632-16-7 间苯氧基溴化苄 | CAS号13826-35-2 3-苯氧基苄醇 | CAS号591-50-4 碘苯 | CAS号22446-38-4 (3-羟苯基)乙酸乙酯 | CAS号3586-14-9 3-苯氧基甲苯

合成工艺路线路线简述

    📜2-(3-苯氧基苯基)乙酸甲酯置于sodium Hydroxide体系中,用 甲醇 作为反应溶剂,化学反应 2.0H,反应生成 3-苯氧基苯乙酸
    参考文献:1-(1-Arylethylpiperidin-4-yl)Thymine 类似物作为抗分枝杆菌 Tmpk 抑制剂
    标题:1-(1-Arylethylpiperidin-4-yl)Thymine 类似物作为抗分枝杆菌 Tmpk 抑制剂
    摘要:合成了一系列基于报道的化合物 3 的结核分枝杆菌 Tmpk (Mtbtmpk) 抑制剂,并评估了它们抑制 Mtbtmpk 催化活性和强毒结核分枝杆菌菌株 (H37Rv) 生长的能力.对 3 支架的修饰未能显着改善 Mtbtmpk 抑制活性和抗分枝杆菌活性.3 的 D 环取代模式的优化导致化合物 21J 具有改善的 Mtbtmpk 抑制效力(三倍)和 H37Rv 生长抑制活性(两倍).将 21J 的 3-氯取代基移到对位得到异构体 21H,尽管 Ic50 值增加了 10 倍,但显示出有希望的全细胞活性(最小抑制浓度 (Mic) = 12.5 μm).
    DOI:10.3390/molecules25122805

    海关参考信息

    专利信息


    专利号:US-7390801-B2
    优先权日:1996-12-23
    标题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THORSETT EUGENE D; PLEISS MICHAEL A; LATIMER LEE H; JOHN VARGHESE; FREEDMAN STEPHEN; BRITTON THOMAS C; AUDIA JAMES A; REEL JON K; DRESSMAN BRUCE A; DROSTE JAMES J; HENRY STEVEN S; STUCKY RUSSELL D; PORTER WARREN J
    权利人:ATHENA NEUROSCIENCES INC; LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:EA-002100-B1
    优先权日:1996-12-23
    标题:CYCLOALCYL COMPOUNDS, LACTAMS, LACTONES AND RELATED COMPOUNDS CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS AND METHODS OF INHIBITING THE SURVIVAL AND / OR SYNTHESIS OF β-AMYLOUS PEPTIDE SOFTWARE AGREED SOFTWARE, SOFTWARE, SOFTWARE, SOFTWARE, SOFTWARE, SOFTWARE, SOFTWARE, SOFTWARE, SOFTWARE, SOFTWARE, SOFTWARE AND SOFTWORK

    专利号:US-2002045747-A1
    优先权日:1996-12-23
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

    专利号:US-2002052359-A1
    优先权日:1996-12-23
    标题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting B-amyloid peptide release and/or its synthesis by use of such compounds

    专利号:US-2002173504-A1
    优先权日:1996-12-23
    标题 :Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting B-amyloid peptide release and/or its synthesis by use of such compounds

    专利号:US-2004043977-A1
    优先权日:1996-12-23
    标题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1021/jm9703404
    摘要:Hajduk PJ, Dinges J, Miknis GF, Merlock M, Middleton T, Kempf DJ, Egan DA, Walter KA, Robins TS, Shuker SB, Holzman TF, Fesik SW. NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein. J Med Chem. 1997 Sep 26;40(20):3144–50. doi: 10.1021/jm9703404.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知